Scientific Publications Database

Article Title: Tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) with ribociclib (RIB) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-7 subgroup analysis
Authors: Bardia, A.; Campos-Gomez, S.; Hurvitz, S. A.; Lu, Y-S.; Im, S-A.; Franke, F.; Chow, L.; Wheatley-Price, P.; Melo Cruz, F.; Alam, J.; Kong, O.; Diaz-Padilla, I.; Miller, M.; Tripathy, D.
Journal: ANNALS OF ONCOLOGY Volume 29
Date of Publication:2018
Abstract:
.